CD274 and cancer: Recent studies have demonstrated that compounds derived from natural extracts such as berberine, luteolin, apigenin, and cosmosiin have the potential to reactivate anti-cancer immune responses and improve therapeutic efficacy by modulating either constitutive or inducible PD-L1 expression in cancer cells [11,12,13,14].